Metallomics for drug development: an integrated CE-ICP-MS and ICP-MS approach reveals the speciation changes for an investigational ruthenium(iii) drug bound to holo-transferrin in simulated cancer cytosol
出版年份 2013 全文链接
标题
Metallomics for drug development: an integrated CE-ICP-MS and ICP-MS approach reveals the speciation changes for an investigational ruthenium(iii) drug bound to holo-transferrin in simulated cancer cytosol
作者
关键词
-
出版物
Metallomics
Volume 5, Issue 8, Pages 955
出版商
Royal Society of Chemistry (RSC)
发表日期
2013-06-07
DOI
10.1039/c3mt00092c
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- X-ray Absorption Near Edge Structure Spectroscopy to Resolve the in Vivo Chemistry of the Redox-Active Indazolium trans-[Tetrachlorobis(1H-indazole)ruthenate(III)] (KP1019)
- (2013) Alfred A. Hummer et al. JOURNAL OF MEDICINAL CHEMISTRY
- Redox activation of metal-based prodrugs as a strategy for drug delivery
- (2012) Nora Graf et al. ADVANCED DRUG DELIVERY REVIEWS
- Proteomic and Metallomic Strategies for Understanding the Mode of Action of Anticancer Metallodrugs
- (2012) Chiara Gabbiani et al. Anti-Cancer Agents in Medicinal Chemistry
- Element Speciation Analysis Using Capillary Electrophoresis: Twenty Years of Development and Applications
- (2012) Andrei R. Timerbaev CHEMICAL REVIEWS
- Analytical Approaches for Assaying Metallodrugs in Biological Samples: Recent Methodological Developments and Future Trends
- (2012) Andrei Timerbaev et al. CURRENT DRUG METABOLISM
- Distinct cellular fates for KP1019 and NAMI-A determined by X-ray fluorescence imaging of single cells
- (2012) Jade B. Aitken et al. Metallomics
- Advances of CE-ICP-MS in speciation analysis related to metalloproteomics of anticancer drugs
- (2012) Andrei R. Timerbaev et al. TALANTA
- Ruthenium anticancer compounds: myths and realities of the emerging metal-based drugs
- (2011) Alberta Bergamo et al. DALTON TRANSACTIONS
- Influence of ascorbic acid on the activity of the investigational anticancer drug KP1019
- (2011) Caroline Bartel et al. JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY
- Metall(prote)omic studies by capillary electrophoresis using separation capillary as an in-line reactor
- (2011) Andrei R. Timerbaev et al. Metallomics
- Recent progress in the application of analytical techniques to anticancer metallodrug proteomics
- (2011) A.R. Timerbaev et al. TRAC-TRENDS IN ANALYTICAL CHEMISTRY
- Ruthenium-based chemotherapeutics: are they ready for prime time?
- (2010) Emmanuel S. Antonarakis et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Pharmacokinetics of a novel anticancer ruthenium complex (KP1019, FFC14A) in a phase I dose-escalation study
- (2009) Frederike Lentz et al. ANTI-CANCER DRUGS
- A categorization of metal anticancer compounds based on their mode of action
- (2009) Teresa Gianferrara et al. DALTON TRANSACTIONS
- Recent developments in ruthenium anticancer drugs
- (2009) Aviva Levina et al. Metallomics
- Capillary electrophoresis coupled to mass spectrometry for biospeciation analysis: critical evaluation
- (2009) A.R. Timerbaev TRAC-TRENDS IN ANALYTICAL CHEMISTRY
- Capillary electrophoresis hyphenated to inductively coupled plasma-mass spectrometry: A novel approach for the analysis of anticancer metallodrugs in human serum and plasma
- (2008) Michael Groessl et al. ELECTROPHORESIS
- Application of capillary electrophoresis–inductively coupled plasma mass spectrometry to comparative studying of the reactivity of antitumor ruthenium(III) complexes differing in the nature of counter-ion toward human serum proteins
- (2008) Kasia Połeć-Pawlak et al. JOURNAL OF CHROMATOGRAPHY A
- CE-ICP-MS for studying interactions between metals and biomolecules
- (2008) Xue-Bo Yin et al. TRAC-TRENDS IN ANALYTICAL CHEMISTRY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now